Skip to main content
. 2019 Dec 10;9:18678. doi: 10.1038/s41598-019-55068-z

Table 2.

Molecularly stratified clinical trial simulations.

Drug Biomarker negative Biomarker positive Relative benefit
Trientine 7 11 4
Wee1 inhibitor 17 18 1
Birinapant 8 11 3

Median PFI values for two treatment arms in MSCTS and relative benefit of patient stratification. The values are presented in months.